News & Updates

Evolent Health, a health care analytics company, raised $100M in Series B funding from The Advisory Board, UPMC Health Plan and TPG Growth. This brings Evolent’s total funding to $124.5M.

Amulyte, a medical device company, launched an equity-based crowdfunding campaign at, to help bring its emergency response system to market. The device wirelessly reports falls and inactivity, and is targeted at seniors living independently and retirement homes.

Predilytics, a health care analytics company, raised undisclosed amount in additional funding from Foundation Medical Partners, and added Andrew D. Firlik, Managing Partner of Foundation Medical Partners to its board of directors.

Rite Aid, a national pharmacy chain, partnered with Text4baby, a free text messaging service for pregnant women and mothers of infants under age one, to provide them with important health and safety information. Rite Aid is also offering free flu shots to users enrolling in this service.

Sharecare, an online health and wellness engagement platform founded by Jeff Arnold and Dr. Mehmet Oz, announced it secured a strategic investment from Heritage Group. The round brings Sharecare’s total funding to $91 million.

Intermountain Healthcare, a health care system known for its leadership and attention to quality, signed a multi-year contract with Cerner to deploy Cerner’s electronic medical record and revenue cycle technology across all of Intermountain’s hospitals and clinics.

The Patient Advocate Foundation and National Patient Advocate Foundation announced a new resource, the Cancer Insurance Checklist, in their suite of patient materials to help cancer patients interact with the new health insurance marketplaces.

Mount Sinai Medical Center hired Facebook’s first data scientist to lead the design of the hospital’s new computing cluster. The system will focus on predictive analytics to help reduce costs.

Neurotrack announced a $2 million Series A round led by Founders Fund and joined by The Social+Capital Partnership.

Leave a Reply

Your email address will not be published. Required fields are marked *